<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pediatric Hematology/Oncology and Immunopathology</journal-id><journal-title-group><journal-title xml:lang="en">Pediatric Hematology/Oncology and Immunopathology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы гематологии/онкологии и иммунопатологии в педиатрии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-1708</issn><issn publication-format="electronic">2414-9314</issn><publisher><publisher-name xml:lang="en">Fund Doctors, Innovations, Science for Children</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">389</article-id><article-id pub-id-type="doi">10.24287/1726-1708-2020-19-3-95-104</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CLINICAL OBSERVATIONS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ НАБЛЮДЕНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">When the disease goes beyond the skin, changes in the skin can be a sign of systemic disease</article-title><trans-title-group xml:lang="ru"><trans-title>Когда болезнь выходит за пределы кожи – изменения на коже могут быть признаком системного заболевания</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7265-0414</contrib-id><name-alternatives><name xml:lang="en"><surname>Khachatryan</surname><given-names>L. A.</given-names></name><name xml:lang="ru"><surname>Хачатрян</surname><given-names>Л. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>cand. med. sci., Head of Box Department of Hematology/Oncology,</p><p>117997, Moscow, Samory Mashela st., 1</p></bio><bio xml:lang="ru"><p>канд. мед. наук, заведующая боксированным отделением гематологии/ онкологии,</p><p>117997, Москва, ул. Саморы Машела, 1 </p></bio><email>lili.2510@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4367-5975</contrib-id><name-alternatives><name xml:lang="en"><surname>Nikolaeva</surname><given-names>D. M.</given-names></name><name xml:lang="ru"><surname>Николаева</surname><given-names>Д. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>117997, Moscow, Samory Mashela st., 1</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8129-0545</contrib-id><name-alternatives><name xml:lang="en"><surname>Shcherbakov</surname><given-names>A. P.</given-names></name><name xml:lang="ru"><surname>Щербаков</surname><given-names>А. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>117997, Moscow, Samory Mashela st., 1</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Healthcare of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-09-08" publication-format="electronic"><day>08</day><month>09</month><year>2020</year></pub-date><volume>19</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>95</fpage><lpage>104</lpage><history><date date-type="received" iso-8601-date="2020-10-05"><day>05</day><month>10</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-10-05"><day>05</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, «D. Rogachev NMRCPHOI»</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">«D. Rogachev NMRCPHOI»</copyright-holder><copyright-holder xml:lang="ru">ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://hemoncim.com/jour/article/view/389">https://hemoncim.com/jour/article/view/389</self-uri><abstract xml:lang="en"><p>Infantile hemangioma may be accompanied by malformations of internal organs and blood vessels. In 1996 PHACE syndrome was defined as a disease which is characterized by the association of segmental infantile hemangioma with localization in the head/neck region and the presence of malformations in the posterior cranial fossa, abnormalities of arterial blood vessels including coarctation of the aorta, heart defects, as well as malformations of the eyes and central nervous system. This article presents a clinical case of a child who was diagnosed this syndrome at the age of 1.5 months based on the presence of segmental hemangioma, as well as large and small criteria specific for this disease. In addition to the main symptoms, the child had an accompanying pathology: Wolff–Parkinson–White syndrome. Therapy with non-selective b-blockers and polychemotherapy allowed stopping already developed and prevent possible complications associated with this syndrome. Parents gave their consent to use information about the child, including fotos, in the article.</p></abstract><trans-abstract xml:lang="ru"><p>Инфантильная гемангиома может сопровождаться наличием мальформаций со стороны внутренних органов и сосудов. В 1996 г. было дано определение PHACE-синдрому как заболеванию, которое характеризуется ассоциацией сегментарной инфантильной гемангиомы с локализацией в области головы/шеи и наличием мальформаций в задней черепной ямке, аномалий крупных артериальных сосудов, включая коарктацию аорты, пороков сердца, а также пороков развития глаз и центральной нервной системы. В данной статье представлен клинический случай ребенка, которому PHACEсиндром был диагностирован в возрасте 1,5 месяца на основании наличия сегментарной гемангиомы, а также больших и малых критериев, характерных для данного заболевания. Кроме основных симптомов у ребенка имела место сопутствующая патология: синдром Вольфа– Паркинсона–Уайта. Лечение неселективными b-блокаторами и полихимиотерапия позволили купировать уже развившиеся и предотвратить возможные осложнения, связанные с данным синдромом. Родители дали согласие на использование информации, в том числе фотографий ребенка, в научных исследованиях и публикациях.</p></trans-abstract><kwd-group xml:lang="en"><kwd>infantile hemangioma</kwd><kwd>segmental hemangioma</kwd><kwd>PHACE syndrome</kwd><kwd>b-blockers</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>инфантильная гемангиома</kwd><kwd>сегментарная гемангиома</kwd><kwd>PHACE-синдром</kwd><kwd>b-блокаторы</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Kilcline C., Frieden I.J. Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol 2008; 25 (2): 168–73. DOI: 10.1111/j.1525-1470.2008.00626.x</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Yilmaz L., Kacenelenbogen N. Les anomalis vasculaires catunées chez l'enfant. Rev Med Brux 2015; 36 (4): 348–57.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Yilmaz L., Dangoisse C., Semaille P. Hémangiome infantile du nourisson et propranolol: une “revolution” thérapeutique. Revue de la literature. Rev Med Brux 2013; 34 (6): 479–84.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Hess C.P., Fullerton H.J., Metry D.W., Drolet B.A., Siegel D.H., Augeste K.I., et al. Cervical and intracranial arterial anomalies in 70 patients with PHACE syndrome. AJNR Am J Neuroradiol 2010; 31 (10): 1980–6. DOI: 10.3174/ajnr.A2206</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Rotter A., Samorano L.P., RivittiMachado M.C., Prado Oliveira Z.N., Gontigo B. PHACE syndrome: clinical manifestations, diagnostic criteria, and management. An Bras Dermatol 2018; 93 (3): 405–11. DOI: 10.1590/abd1806-4841.20187693</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Garzon M.C., Epstein L.G., Heyer G.L., Frommelt P.C., Orbach D.B., Baylis A.L., et al. PHACE Syndrome: Consensus-Derived Diagnosis and Care Recommendations. J Pediatr 2016: 178: 24–33.e2. DOI: 10.1016/j.jpeds.2016.07.054</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Raas-Rothschild A., Nir A., Gillis R., Rein A.J. Giant condenital aortic aneurysm with cleft sternum, supraumbilical raphe, and hemangiomatosis: report and review. Am J Genet 2000; 90 (3): 243–5. DOI: 10.1002/(sici)1096-8628(20000131)90:33.0.co;2-1</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Pascual-Castroviejo I. Vascular and nonvascular intracranial malformation associated with external capillary hemangiomas. Neuroradiology 1978; 16: 82–4. DOI: 10.1007/BF00395211</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Frieden I.J., Reese V., Cohen D. PHACE syndrome. The association of fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol 1996; 132 (3): 307–11. DOI: 10.1001/archderm.132.3.307</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Metry D.W., Heyer G., Hess C., Garzon M., Haggstrom A., Frommelt P., et al. Consensus Statement on Diagnostic Criteria for PHACE Syndrome. Pediatrics 2009; 124 (5): 1447–56. DOI: 10.1542/peds.2009-0082</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Nabatian A.S., Milgraum S.S., Hess C.P., Mancini A.J., Krol A., Frieden I.J. PHACE without face? Infantile hemangiomas of the upper body region with minimal or absent facial hemangiomas and associated structural malformations. Pediatr Dermatol 2011; 28 (3): 235–41. DOI: 10.1111/j.1525-1470.2011.01407.x</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Metry D.W., Haggstrom A.N., Drolet B.A., Baselga E., Chamlin S., Garzon M., et al. A prospective study of PHACE syndrome in infantile hemangiomas: dermographc features, clinical findings, and complications. Am J med Genet A 2006; 140 (9): 975–86. DOI: 10.1002/ajmg.a.31189</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Haggstrom A.N., Lammer E.J., Schneider R.A., Marcucio R., Frieden I.J. Patterns of Infantile Hemangiomas: New Clues to Hemangioma Pathogenesis and Embrionic Facial Development. J Pediatr 2006; 117 (3): 698–703. DOI: 10.1542/peds.2005-1092</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Haggstrom A.N., Garson M.C., Baselga E., Chamlin S.L., Frieden I.J., Holland K., et al. Risk for PHACE syndrome in infant with large facial hemangioma. Pediatrics 2010; 126 (2): е418–26. DOI: 10.1542/peds.2009-3166</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Poetke M., Frommeld T., Berlien H.P. PHACE syndrome: new views on diagnostic criteria. Eur J Pediatr Surg 2002; 12 (6): 366. DOI: 10.1055/s-2002-36849</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Metry D., Frieden I.J., Hess C., Siegel D., Maheshwari M., Baselga E., et al. Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants. Pediatr Dermatol 2013; 30 (1): 71–89. DOI: 10.1111/j.1525-1470.2012.01879.x</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Bayer M.L., Frommlet P.C., Blei F., Breur J.M., Cordisco M.R., Frieden I.J., et al. Congenital cardiac, aortic arch, and vascular bed anomalies in PHACE syndrome (from the International PHACE Syndrome Registry). Am J Cardiol 2013; 112 (12): 1948–52. DOI: 10.1016/j.amjcard.2013.08.025</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Hartemink D.A., Chiu Y.E., Drolet B.A., Kerschner J.E. PHACES syndrome: a review. Int J Pediatr Otorhinolaryngol 2009; 73 (2): 181–7. DOI: 10.1016/j.ijporl.2008.10.017</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Martin K.L., Arvedson J.C., Bayer M.L., Drolet B.A., Chun R., Siegel D.H. Risk of dysphagia and speech and language delay in PHACE syndrome. Pediatr Dermatol 2015; 32 (1): 64–9. DOI: 10.1111/pde.12447</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Rudnick E.F., Chen E.Y., Manning S.C., Perkins J.A. PHACE syndrome: otolaryngic considerations in recommendation and management. Int J Pediatr Otorhinolaryngol 2009; 73 (2): 281–8. DOI: 10.1016/j.ijporl.2008.10.018</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Chiller K.G., Passaro D., Frieden I.J. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol 2002; 138 (12): 1567– 676. DOI: 10.1001/archderm.138.12.1567</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Antonov N.K., Spence-Shishido A., Marathe K.S., Tlougan B., Kazim M., Sultan S., et al. Orbital hemangioma with intracranial vascular anomalies and hemangiomas: a new presentation of PHACE Syndrome. Pediatr Dermatol 2015; 32 (6): е267–72. DOI: 10.1111/pde.12695</mixed-citation></ref></ref-list></back></article>
